All India Institute of Medical Sciences, New Delhi, INDIA, have been actively involved in stem cell research in various degenerative disorders.

The Stem Cell Facility was established in 2005 to explore the safety, feasibility and the efficacy of autologous hematopoietic and cord blood stem cell transplantation in degenerative diseases. As of now, 360 patients have undergone this therapy,says, the Director of AIIMS, Dr Venugopal.

Some of the diseases covered are myocardial infarction, dilated cardiomyopathy, cerebral palsy, motor neuron disease, biliary atrisis, spina bifida, macular degeneration, retinitis pigmentosa, fracture non-union, peripheral vascular disease and acute ischaemic stroke.

A PhD programme has been introduced. AIIMS have also imparted short-term training in stem cell techniques to under-graduate and postgraduate students. At the moment, 10 departments are involved in both clinical and basic research in stem cells.

About AIIMS


  • Govt. of India Agrees to Provide Rs. 22 Crores for Stem Cell Research Facility in CCMB
  • Reliance Life Sciences Files US Patent for Improved Techniques to Harvest Stem Cells from Embryonic and Placental Cord Blood Cells
  • Success Rate of Stem Cell therapy in India is Highly Encouraging
  • Stem Cell Research is Steadily Spreading its Root in India
  • India Plans to Join a Handful of Countries Regulating Stem Cells
  • India Launched First Stem Cell Transplant Centre to Cure Killer Diseases
  • Stem Cell Heart Study To Begin in Thailand
  • Stem Cells Research Initiatives in India
  • Indians Becoming Aware of Preserving Cord Blood as an Insurance for Their Children
  • Private Stem Cell Research in India